NWPHF
US OTC
Newron Pharmaceuticals S.p.A
Overview
NWPHF
Symbol
US OTC
Exchange
About stock

Newron Pharmaceuticals S.p. A., a clinical stage biopharmaceutical company, focuses on the research and development, manufacture, and distribution of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease.

Its product pipeline comprises Evenamide, a first add-on therapy for the treatment of patients with positive symptoms of schizophrenia; and Ralfinamide for patients with specific rare pain indications. Newron Pharmaceuticals S.p. A. was founded in 1999 and is headquartered in Bresso, Italy.

Newron Pharmaceuticals S.p.A dividend calculator
Report issue